Silva, Vanessa K A <br/><br/>
Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.  [electronic resource] 

 -  Medical mycology  Oct 2020 
 - 928-937 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1460-2709 
<br/><br/><label>Standard No.: </label>10.1093/mmy/myz132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antifungal Agents--therapeutic use<br/>Cryptococcosis--drug therapy<br/>Cryptococcus gattii--drug effects<br/>Cryptococcus neoformans--drug effects<br/>Disease Models, Animal<br/>Ergosterol--metabolism<br/>Genetic Variation<br/>Genotype<br/>Humans<br/>Macrophages--drug effects<br/>Mice<br/>Oximes--therapeutic use<br/>Pyridines--therapeutic use